Form 8-K - Current report:
SEC Accession No. 0001683168-22-005100
Filing Date
2022-07-25
Accepted
2022-07-25 12:11:40
Documents
12
Period of Report
2022-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cnbx_8k.htm   iXBRL 8-K 23521
  Complete submission text file 0001683168-22-005100.txt   193447

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cnbx-20220720.xsd EX-101.SCH 2962
3 XBRL LABEL FILE cnbx-20220720_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE cnbx-20220720_pre.xml EX-101.PRE 22791
6 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_8k_htm.xml XML 3464
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 221102243
SIC: 2834 Pharmaceutical Preparations